Artificial Intelligence Powering the Global Medical Imaging Market

Artificial Intelligence Powering the Global Medical Imaging Market

Efficiency Tools and Workflow Optimization to Drive Future Growth Potential

RELEASE DATE
27-Jan-2021
REGION
North America
Research Code: K546-01-00-00-00
SKU: HC03387-NA-TC_25209

$7,500.00

Special Price $6,750.00 save 10 %

In stock
SKU
HC03387-NA-TC_25209

$7,500.00

$6,750.00 save 10 %

DownloadLink

Pay by invoice

ENQUIRE NOW

Description

The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors’ business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing changes in the care standard. On a macro level, government policies on reimbursement and regulations tend to impact industry participants' performance if their internal teams delay the strategic actions needed to thrive in this new environment.

Frost & Sullivan has introduced the medical imaging and informatics industry semi-annual insights tracker to help clients address challenges in a competitive environment. Covering the diagnostic imaging, image-guided therapies, and imaging informatics segments, the tracker will monitor market factors and significant events and qualitatively assess their industry impact.


Research Highlights

Clinical Trends:

  • Disruptive trends impacting the current gold standard
  • Trends indicating the clinical adoption of new solutions/products
  • Essential announcements from associations, such as the Radiological Society of North America (RSNA), European Society of Radiology (ESR), American College of Radiology (ACR), and American College of Cardiology (ACC)

Competition:

  • New product launches  and capabilities
  • Mergers and acquisitions
  • United States Food and Drug Administration (USFDA) and Conformité Européenne (CE) approvals
  • Prominent FDA and CE recalls/warnings

Policies and Regulations:

  • Introduction of region-specific regulatory approvals
  • Reimbursement achievements or setbacks

Event Highlights:

  • Major events highlights, covering significant themes derived by studying the messaging and communications, product launches, and product promotions at the event

Author: Suresh Kuppuswamy

Table of Contents

Why is it Increasingly Difficult to Grow?

The Strategic Imperative 8™

The Impact of the Top Three Strategic Imperatives on the Global Medical Imaging and Informatics Industry

Growth Opportunities Fuel the Growth Pipeline Engine™

Medical Imaging and Informatics Industry Scope of Analysis

Study Indicators—Medical Imaging and Informatics Industry

Executive Summary—Medical Imaging and Informatics Industry

Long-Term Contracts (Customer Acquisitions)—Medical Imaging and Informatics Industry

Long-Term Contracts (Customer Acquisitions)—Medical Imaging and Informatics Industry (continued)

New Launches and Upgrades—Medical Imaging and Informatics Industry

New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)

New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)

New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)

New Launches and Upgrades—Medical Imaging and Informatics Industry (continued)

Mergers and Acquisitions—Medical Imaging and Informatics Industry

Mergers and Acquisitions—Medical Imaging and Informatics Industry (continued)

Mergers and Acquisitions—Medical Imaging and Informatics Industry (continued)

Strategic Partnerships—Medical Imaging and Informatics Industry

Strategic Partnerships—Medical Imaging and Informatics Industry (continued)

Strategic Partnerships—Medical Imaging and Informatics Industry (continued)

Strategic Partnerships—Medical Imaging and Informatics Industry (continued)

USFDA Approvals (MRI)—Medical Imaging and Informatics Industry

USFDA Approvals (CT)—Medical Imaging and Informatics Industry

USFDA Approvals (Ultrasound)—Medical Imaging and Informatics Industry

USFDA Approvals (Ultrasound)—Medical Imaging and Informatics Industry (continued)

USFDA Approvals (Molecular Imaging)—Medical Imaging and Informatics Industry

USFDA Approvals (Fluoroscopy)—Medical Imaging and Informatics Industry

USFDA Approvals (X-Ray)—Medical Imaging and Informatics Industry

USFDA Approvals (X-Ray)—Medical Imaging and Informatics Industry (continued)

USFDA Approvals (Breast Imaging)—Medical Imaging and Informatics Industry

USFDA Approvals (Therapy)—Medical Imaging and Informatics Industry

USFDA Approvals (Software)—Medical Imaging and Informatics Industry

USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)

USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)

USFDA Approvals (Software)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry

USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Jan 2020–Mar 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

USFDA Recalls (Apr 2020–Jun 2020)—Medical Imaging and Informatics Industry (continued)

Clinical Trends—Medical Imaging and Informatics Industry

Clinical Trends—Medical Imaging and Informatics Industry (continued)

Clinical Trends—Medical Imaging and Informatics Industry (continued)

Clinical Trends—Medical Imaging and Informatics Industry (continued)

Clinical Trends—Medical Imaging and Informatics Industry (continued)

Clinical Trends—Medical Imaging and Informatics Industry (continued)

Clinical Trends—Medical Imaging and Informatics Industry (continued)

Policies and Regulations (US)—Medical Imaging and Informatics Industry

Policies and Regulations (US)—Medical Imaging and Informatics Industry (continued)

Policies and Regulations (US)—Medical Imaging and Informatics Industry (continued)

Policies and Regulations (Australia)—Medical Imaging and Informatics Industry

Policies and Regulations (Europe)—Medical Imaging and Informatics Industry

Trending Themes at HIMSS 2020—Medical Imaging and Informatics Industry

Vendor Highlights at HIMSS 2020—Medical Imaging and Informatics Industry

Vendor Highlights at HIMSS 2020—Medical Imaging and Informatics Industry (continued)

Vendor Highlights at American College of Cardiology 2020—Medical Imaging and Informatics Industry

Your Next Steps

Why Frost, Why Now?

List of Exhibits

List of Exhibits (continued)

Legal Disclaimer

Related Research
The medical imaging and informatics industry is evolving, with vendors launching new products and solutions every other day. As the reimbursement environment transitions from fee-for-service to value-based payment, vendors business models and value propositions are changing. New evidence on the use of specific imaging techniques is influencing changes in the care standard. On a macro level, government policies on reimbursement and regulations tend to impact industry participants' performance if their internal teams delay the strategic actions needed to thrive in this new environment. Frost & Sullivan has introduced the medical imaging and informatics industry semi-annual insights tracker to help clients address challenges in a competitive environment. Covering the diagnostic imaging, image-guided therapies, and imaging informatics segments, the tracker will monitor market factors and significant events and qualitatively assess their industry impact.--BEGIN PROMO--

Research Highlights

Clinical Trends:

  • Disruptive trends impacting the current gold standard
  • Trends indicating the clinical adoption of new solutions/products
  • Essential announcements from associations, such as the Radiological Society of North America (RSNA), European Society of Radiology (ESR), American College of Radiology (ACR), and American College of Cardiology (ACC)

Competition:

  • New product launches  and capabilities
  • Mergers and acquisitions
  • United States Food and Drug Administration (USFDA) and Conformité Européenne (CE) approvals
  • Prominent FDA and CE recalls/warnings

Policies and Regulations:

  • Introduction of region-specific regulatory approvals
  • Reimbursement achievements or setbacks

Event Highlights:

  • Major events highlights, covering significant themes derived by studying the messaging and communications, product launches, and product promotions at the event

Author: Suresh Kuppuswamy

More Information
No Index No
Podcast No
Predecessor MF08-01-00-00-00
Author Suresh Kuppuswamy
Industries Healthcare
WIP Number K546-01-00-00-00
Is Prebook No
GPS Codes 9600-B1,9566-B1,9570-B1,99BE-B1,9614-B1